It accelerates the inhibition of prostate cancer cell marker CD44 in vivo and in vitro and also downregulates the hedgehog-Gli1 pathway that contributes to the anticancer stem cell effect of genistein in prostate cancer TCs [175]. The gene discussed is CD44; the disease is Familial prostate cancer.